Zygomycosis presenting as acute myocardial infarction during hematological malignancies

Internal Medicine

Volumn 47, Issue 9, 2008, Pages 839-842

  Joshita, Satoru ^a,b   Kitano, Kiyoshi ^a   Nagaya, Tadanobu ^a,b   Kamijo, Atsushi ^a   Nakazawa, Koh ^a   Ishida, Fumihiro ^b  

^a National Hospital Organization   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute lymphoblastic leukemia; Myelodysplastic syndrome; Myocardial infarction; Zygomycosis

Indexed keywords

AMPHOTERICIN B; ANTINEOPLASTIC AGENT; CATECHOLAMINE; CEFEPIME; CILASTATIN PLUS IMIPENEM; CYCLOPHOSPHAMIDE; CYTARABINE; CYTARABINE 5' STEARYLPHOSPHATE; DOXORUBICIN; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; IMATINIB; ITRACONAZOLE; PREDNISOLONE; VINCRISTINE SULFATE;

ABDOMINAL PAIN; ACUTE HEART INFARCTION; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; AUTOPSY; BONE MARROW BIOPSY; BONE MARROW EXAMINATION; BONE PAIN; CASE REPORT; CONSTIPATION; CORONARY ARTERY THROMBOSIS; COUGHING; CYANOSIS; DEATH; DRUG ERUPTION; ECHOCARDIOGRAPHY; FATALITY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FEVER; HEART ARREST; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPOTENSION; ILEUS; KIDNEY DYSFUNCTION; LOW DRUG DOSE; LYMPHADENOPATHY; MALE; MUCORMYCOSIS; PLEURA EFFUSION; REFRACTORY ANEMIA WITH EXCESS BLASTS; SINUS BRADYCARDIA; SKIN BIOPSY; SKIN INDURATION; THORAX PAIN; ZYGOMYCETES; CORONARY BLOOD VESSEL; HEART INFARCTION; IMMUNE DEFICIENCY; IMMUNOLOGY; LYMPHATIC LEUKEMIA; MICROBIOLOGY; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; PATHOLOGY;

AGED; CORONARY VESSELS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; MYOCARDIAL INFARCTION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; ZYGOMYCOSIS;

EID: 45549095402     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0832     Document Type: Article

References (21)

1. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 13: 236-301, 2000.
2. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis 41: 634-653, 2005.
3. Sugar AM. Mucormycosis. Clin Infect Dis 14 Suppi 1: S126-S129, 1992.
4. Kontoyiannis DP, Lionakis MS, Lewis RE, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 191: 1350-1360, 2005.
5. Pagano L, Ricci P, Tonso A, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Itahano Malattie Ematologiche Maligne dell'Adulto). Br J Haematol 99: 331-336, 1997.
6. Pagano L, Offidani M, Fianchi L, et al. GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) Infection Program. Mucormycosis in hematologic patients. Haematologica 89: 207-214, 2004.
7. Jackman ID Jr, Simonsen RL. The clinical manifestations of cardiac mucormycosis. Chest 101: 1733-1736, 1992.
8. Yanada M, Takeuchi J, Sugiura I, et al. Japan Adult Leukemia Study Group. High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group. J Clin Oncol 24: 460-466, 2006.
9. Brown J. Zygomycosis: an emerging fungal infection. Am J Health Syst Pharm 62: 2593-2596, 2005.
10. Gerson SL, Talbot GH, Hurwitz S, et al. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intent Med 100: 345-351, 1984.
11. Benbow EW, McMahon RF. Myocardial infarction caused by cardiac disease in disseminated zygomycosis. J Clin Pathol 40: 70-74, 1987.
12. Virmani R, Connor DH, McAllister HA. Cardiac mucormycosis. A report of five patients and review of 14 previously reported cases. Am J Clin Pathol 78: 42-47, 1982.
13. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KVI. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 30: 851-856, 2000.
14. Gonzalez CE, Rinaldi MG, Sugar AM. Zygomycosis. Infect Dis Clin North Am 16: 895-914, 2002.
15. Herbrecht R, Denning DW, Patterson TF, et al. Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347: 408-415, 2002.
16. Walsh TJ, Pappas P, Winston DJ, et al. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 346: 225-234, 2002.
17. Walsh TJ, Teppler H, Donowitz GR, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 351: 1391-1402, 2004.
18. Powers JH, Dixon CA, Goldberger MJ. Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever. N Engl J Med 346: 289-290, 2002.
19. Spanakis EK, Aperis G, Mylonakis E. New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage. Clin Infect Dis 43: 1060-1068, 2006.
20. Gubarev N, Separovic J, Gasparovic V, Jelic I. Successful treatment of mucormycosis endocarditis complicated by pulmonary involvement. Thorac Cardiovasc Surg 55: 257-258, 2007.
21. Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med 340: 764-771, 1999.